COBAS 4800 HPV TEST, US-IVD 05235880190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-05-02 for COBAS 4800 HPV TEST, US-IVD 05235880190 manufactured by Roche Molecular Systems.

Event Text Entries

[22191273] A customer site in the us filed a complaint alleging that a (b)(6) result was generated when using the cobas 4800 (b)(4) test. The sample tested (b)(6) for (b)(6) on (b)(6) 2013. The result was released to the physician. The customer ran this sample on (b)(6) 2013 as part of a lot validation run and the sample generated (b)(6) result. This result was not reported to the physician. The customer believes that the original (b)(6) result is correct.
Patient Sequence No: 1, Text Type: D, B5


[22364809] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[30041587] (b)(4). A customer site in the us filed a complaint alleging that (b)(6) results for (b)(6) were generated when using the cobas 4800 hpv test. The sample initially tested (b)(6) for (b)(6). The customer re-ran this sample twice and the sample generated a (b)(6) result both times. The customer reported the initial (b)(6) result and questioned the (b)(6) results. The sample in question was provided for investigative testing, which generated a (b)(6) result. The retain complaint kit generated valid results which met specification. There is no indication of a product malfunction. It is plausible that the (b)(6) result generated at the customer site is due to the effects of the heterogeneous cell specimens. Heterogeneous specimens can give drastically varying results between the initial test and subsequent testings. (b)(6) specimens should be vortexed as described in the package insert to in order to ensure even distribution of target in the testing sample. It was suggested that the customer discuss the results with the physician and correlate with cytology and patient history. It was also suggested that a new collection be obtained for testing. Patient treatment information was requested, but this information was not available. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2013-00009
MDR Report Key3090418
Report Source05
Date Received2013-05-02
Date of Report2013-05-23
Date of Event2013-04-03
Date Mfgr Received2013-05-23
Date Added to Maude2013-07-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS 4800 HPV TEST, US-IVD
Generic NameKIT, DNA DETECTION, HUMAN PAPILLOMA VIRUS
Product CodeMAQ
Date Received2013-05-02
Catalog Number05235880190
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2013-05-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.